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ABSTRACT
ObjeCtive
To describe patterns in maternal gestational weight 
gain (GWG) in healthy pregnancies with good maternal 
and perinatal outcomes.
Design
Prospective longitudinal observational study.
setting
Eight geographically diverse urban regions in Brazil, 
China, India, Italy, Kenya, Oman, United Kingdom, and 
United States, April 2009 to March 2014.
PartiCiPants
Healthy, well nourished, and educated women 
enrolled in the Fetal Growth Longitudinal Study 
component of the INTERGROWTH-21stProject, who had 
a body mass index (BMI) of 18.50-24.99 in the first 
trimester of pregnancy.
Main OutCOMe Measures
Maternal weight measured with standardised methods 
and identical equipment every five weeks (plus/minus 
one week) from the first antenatal visit (<14 weeks’ 
gestation) to delivery. After confirmation that data from 
the study sites could be pooled, a multilevel, linear 
regression analysis accounting for repeated measures, 
adjusted for gestational age, was applied to produce 
the GWG values.
results
13 108 pregnant women at <14 weeks’ gestation were 
screened, and 4607 met the eligibility criteria, 
provided consent, and were enrolled. The variance 
within sites (59.6%) was six times higher than the 
variance between sites (9.6%). The mean GWGs were 
1.64 kg, 2.86 kg, 2.86 kg, 2.59 kg, and 2.56 kg for the 
gestational age windows 14-18+6 weeks, 19-23+6 weeks, 
24-28+6 weeks, 29-33+6 weeks, and 34-40+0 weeks, 
respectively. Total mean weight gain at 40 weeks’ 
gestation was 13.7 (SD 4.5) kg for 3097 eligible women 
with a normal BMI in the first trimester. Of all the 
weight measurements, 71.7% (10 639/14 846) and 
94.9% (14 085/14 846) fell within the expected 1 SD 
and 2 SD thresholds, respectively. Data were used to 
determine fitted 3rd, 10th, 25th, 50th, 75th, 90th, and 
97th smoothed GWG centiles by exact week of 
gestation, with equations for the mean and standard 
deviation to calculate any desired centiles according to 
gestational age in exact weeks.
COnClusiOns
Weight gain in pregnancy is similar across the eight 
populations studied. Therefore, the standards 
generated in this study of healthy, well nourished 
women may be used to guide recommendations on 
optimal gestational weight gain worldwide.
Introduction
Associations between insufficient or excessive gesta-
tional weight gain (GWG) and short and long term 
maternal and child health outcomes are well described.1 
Insufficient weight gain has been linked with increased 
risks of low birth weight, small for gestational age, and 
preterm birth, while excessive gain has been associated 
with large for gestational age, gestational diabetes, 
preterm birth, caesarean section, infant mortality, post-
partum weight retention, and childhood obesity.2-9 
Pregnant women are therefore routinely weighed in 
clinical settings. The benefits of doing so, however, are 
debatable in the absence of appropriate guidelines or 
even agreement on what constitutes adequate weight 
gain.10 11
In 1970, the Institute of Medicine/National Research 
Council reviewed the available evidence on GWG that 
resulted in good pregnancy outcomes, with subsequent 
revisions in 1990 and 2009.1 12 13  The latest guidelines 
evaluated the trade offs between maternal and child 
health outcomes and weight gain during pregnancy, 
WhAT IS AlReAdy knoWn on ThIS TopIC
Guidelines and charts for gestational weight gain (GWG) that are currently in use 
around the world were derived from country specific studies
A recent systematic review assessing the quality of these studies has shown 
considerable heterogeneity in methods, in particular in terms of sample selection, 
study design, and methods of data collection and statistical analysis
This could explain the variation in recommendations and the lack of consensus 
regarding what constitutes adequate weight gain
WhAT ThIS STudy AddS
This multi-country study of GWG adopted a prescriptive and highly standardised 
approach to describing the GWG patterns of normal weight women at low risk of 
adverse maternal and perinatal outcomes
The generated standards could be used to alert clinicians to deviations in weight, 
which should then initiate a series of questions to determine whether the changes 
are associated with complications related to pregnancy, medical conditions, or 
eating disorders
These standards are more scientifically robust than other published charts and add 
to the set of international standards from the INTERGROWTH-21st Project
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including the risks of small for gestational age and 
preterm birth with inadequate GWG and the increased 
rates of caesarean section and postpartum weight 
retention with excessive GWG. Based on a recent sys-
tematic review, however, these guidelines were all 
derived from country specific studies that varied in 
sample selection, study design, and methods of data 
collection and statistical analysis.14  In the United King-
dom, “routine weighing during pregnancy should be 
confined to circumstances in which clinical manage-
ment is likely to be influenced.”15  In countries where 
routine weighing is recommended, most current guide-
lines are based on relating observed GWG to pregnancy 
outcomes and then determining the range of weight 
gain with the lowest perinatal risk,1 16-18 although other 
authors have attempted to select populations with good 
perinatal outcomes and then retrospectively determine 
the associated GWG range.19-22
The World Health Organization recommends that a 
reference for GWG be based on prospective longitudinal 
studies of selected populations with a low incidence of 
maternal and fetal complications, where anthropomet-
ric measures are collected before and during pregnancy 
and postpartum.23  The same “prescriptive” approach 
was adopted by WHO in producing international 
growth standards for children aged 0-5 years that have 
now been adopted by more than 125 countries world-
wide,24 and by the International Fetal and Newborn 
Growth (INTERGROWTH-21st) Consortium for the 
21stCentury in producing standards for early pregnancy 
dating,25  fetal growth,26  newborn size,27  and postnatal 
growth for preterm infants.28  We examined data on 
GWG obtained, according to WHO recommendations, 
from healthy pregnant women who were free from iden-
tifiable major medical, nutritional, or social and major 
environmental risk factors.26 29 30  The women had preg-
nancies with good maternal and perinatal outcomes.31 
Based on these data, we report GWG patterns from nor-
mal weight women.
Methods
study site and population selection
INTERGROWTH-21st was a multicentre multiethnic 
population based project conducted between April 
2009 and March 2014 in eight well defined urban sites: 
Pelotas (Brazil), Turin (Italy), Muscat (Oman), Oxford 
(UK), Seattle (US), Shunyi County in Beijing (China), 
the central area of Nagpur (India), and the Parklands 
suburb of Nairobi (Kenya). The primary aim was to 
produce international standards for fetal, newborn, 
and preterm growth using the same conceptual frame-
work as the WHO Multicentre Growth Reference 
Study24 30 32 to complement the existing WHO Child 
Growth Standards.
We recruited women who started antenatal care 
before 14 weeks’ gestation with reliable menstrual dates 
and a confirmatory ultrasound dating scan who met the 
entry criteria of optimal health, nutrition, education, 
and socioeconomic status and were not exposed during 
pregnancy to environmental hazards.25 29 30 These low 
risk women constituted the population of the Fetal 
Growth Longitudinal Study (FGLS) component of the 
INTERGROWTH-21st Project.26
Measurements
A detailed manual with instructions for all adult mea-
surement techniques, the methods for multicentre stan-
dardisation of those measures, and the procedures for 
the calibration and maintenance of equipment have 
been published elsewhere.33-35 All documentation, pro-
tocols, data collection forms, and electronic transfer 
strategies are available atwww.intergrowth21.org. 
Briefly, the women’s height and weight were measured 
in duplicate with a Seca 264 stadiometer and Seca 877 
scale (Seca, Germany), respectively, on study entry 
between 9 and 13+6 weeks’ gestation. A first trimester 
body mass index (BMI) was calculated and categorised 
as normal weight (18.50-24.99) or overweight (25.00-
29.99), according to the WHO definition.36  The same 
standardised methods and clinical procedures were 
used to measure maternal weight every five weeks 
(plus/minus one week) until delivery, so that the possi-
ble ranges after recruitment in which weight was mea-
sured were 14-18, 19-23, 24-28, 29-33, 34-38, and 39-42 
weeks’ gestation.35
statistical analyses
GWG was calculated as the measured weight at each 
antenatal visit minus the measured weight in the first 
trimester. According to prespecified criteria, we 
excluded pregnancies complicated by fetal death or 
congenital abnormality, catastrophic or severe medical 
conditions (such as cancer or HIV), those with severe 
unanticipated conditions related to pregnancy that 
required admission to hospital (such as eclampsia or 
severe pre-eclampsia), and those identified during the 
study who no longer fulfilled the entry criteria (such as 
women who started smoking during pregnancy or had 
an episode of malaria).
The first step was to assess variation in GWG across 
sites and whether we could pool the data. A detailed 
analysis of the methods used to assess the similarity of 
fetal and newborn data from all eight INTER-
GROWTH-21st sites to permit pooling has been reported 
elsewhere.31 37  We applied the same methods to the 
GWG data by using variance component analysis (anal-
ysis of variance (ANOVA)) to calculate the percentage of 
variance in the longitudinal weight measurements from 
variance between sites adjusted for gestational age 
(fixed effects) while sites and individuals were treated 
as random effects, and a standardised site difference 
(SSD), similar to a z score, calculated as the difference 
between the mean of one site and the mean of all sites 
together. Each difference was then expressed as a pro-
portion of the all sites’ standard deviation (SD) (that is, 
SD of the data pooled across all sites) at each corre-
sponding gestational age. The SSD allows for direct 
comparisons across gestational age windows, and we 
prespecified a value of ≤0.5 as adequate for combining 
data from all sites. This is similar to the cut off used in 
the WHO Multicentre Growth Reference Study to create 
international standards for infant and child growth.38
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In a second step we constructed smoothed centiles of 
GWG according to gestational age. The statistical meth-
ods we used were informed by the recommendations of 
Altman and Royston39 40  and recent literature reviews.41 42
We applied a multilevel linear regression analysis 
accounting for repeated measures, adjusting for gesta-
tional age, which we treated as a fixed effect, whereas 
sites and individuals were treated as random effects.38 
As weight gain exhibited a non-normal distribution, we 
log transformed (natural log) data to stabilise variance 
and transform the data to normality. We added a con-
stant 8.5 for normal weight women to all values to shift 
the minimum value of the distribution to 1 to ensure no 
negative values when we modelled on the log scale. The 
best fitting powers for the mean weight gain were pro-
vided by second degree fractional polynomials and fur-
ther modelled in a multilevel framework to account for 
the longitudinal design of the study (repeated mea-
sures). The data structure comprises two levels—that is, 
measurements within and between women. Therefore, 
we fitted a random effects model (two level hierarchical 
structure) to the longitudinal GWG measurements as a 
function of gestational age using therunmlwin package 
in STATA.43 To obtain an equation for the SD, we mod-
elled the resulting variance components from the mul-
tilevel model that accounts for the correlations between 
and within women using fractional polynomials. The 
SD was modelled on the log scale to stabilise variance. 
Assessment of goodness of fit incorporated a visual 
inspection of the overall model fit by comparing empir-
ical centiles (calculated per completed week of gesta-
tion—for example, 38 weeks’ gestation=38-38+6 weeks’ 
gestation) to the fitted centiles; a quantile-quantile 
(q-q) plot of the residuals; and a plot of fitted z scores 
across gestational ages.
As the first weight measurement was taken between 
9 and 13+6 weeks’ gestation, we performed a sensitiv-
ity analysis to explore the likelihood of potential bias 
that might arise as a result of this classification. Based 
on a reported range in weight gain of 0.5-2 kg in the 
first trimester,1 we performed a post hoc analysis to 
estimate the proportion of women who were within 2 
kg of the lower limit in the normal weight group (and 
so could have been underweight before conception) 
and, similarly, those within 2 kg of the lower cut off 
for overweight women, as they might actually have 
been normal weight before conception. The data were 
modelled with the same analytical strategy and the 
resultant centiles compared with those obtained from 
our original classification of normal weight (that is, 
based on the first trimester BMI). All analyses were 
performed in STATA, version 11.2, software (StataCorp 
LP, College Station, TX, US). Furthermore, to rule out 
potential bias from caesarean section, we performed 
a sensitivity analysis excluding all births by caesar-
ean section and refitting the final model to the 
remaining data and compared this with the model 
using all the data.
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are 
no plans to involve patients in dissemination.
Results
A total of 13 108 pregnant women at <14 weeks’ gesta-
tion were screened (fig 1), and 4607 met the eligibility 
criteria, provided consent, and were enrolled in the 
Fetal Growth Longitudinal Study. The contribution from 
each site to the total enrolled sample population ranged 
from 311 (7%) for the US to 640 (14%) for the UK.
The most common reasons for ineligibility were 
maternal height <153 cm (1022/8501; 12%), BMI ≥30 
(1009/8501; 12%), and age <18 or >35 years (915/8501; 
11%) at screening. During the pregnancy, 71 women 
were lost to follow-up or withdrew consent and 36 
were excluded (during pregnancy 29 had severe medi-
cal conditions, six took up smoking, and one used rec-
reational drugs). After exclusion of 78 miscarriages, 
terminations, or stillbirths, there were 4422 live single-
ton births of which a further 101 were excluded 
because of congenital malformations. Of the 4321 
remaining women, eight were excluded from the anal-
ysis (four with only one weight measurement during 
pregnancy and four who were obvious outliers 
because of illogical values that could not be corrected 
during data cleaning). We excluded nine observations 
with extreme weight changes (defined as a gain or loss 
of >5 kg/week).
Our final sample therefore consisted of 4313 women 
who contributed 24 977 weight measurements. Of these, 
3097 (72%) women had normal weight in the first tri-
mester. Here we report the analyses pertaining to these 
Live births with congenital
malformation (n=101)
Live births without congenital
malformation (n=4321)
Number of women interviewed (n=13 108)
Number of women enrolled (n=4607)
Women and newborns with pregnancy and delivery information (n=4500)
Live births (n=4422)
Overweight women (n=1216)Normal weight women (n=3097)
Excluded (n=107):
  Severe maternal conditions (n=29)
  Smoking (n=6)
  Recreational drugs (n=1)
  Lost to follow-up or withdrew consent (n=71)
Women ineligible at screening
or by ultrasound (n=8501)
Miscarriages, terminations
and still births (n=78)
Excluded (n=8):
  Obvious outlier (n=4)
  Only one weight measurement (n=4)
Fig 1 | Flowchart for selecting women included in study of gestational weight gain
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normal weight women whose data were used to con-
struct the international GWG standard.
The demographic characteristics of the study cohort 
were similar across the eight sites and have been 
reported elsewhere.31  Women had a median of six 
weight measurements (range 2-7); median gestational 
age at first antenatal visit was 11.9 weeks (SD 1.4 weeks); 
mean maternal age was 28.2 (SD 3.8) years; 97% 
(3020/3097) were married or living with a partner, and 
72% (2230/3097) were nulliparous. Table 1  shows socio-
demographic information and pregnancy and perinatal 
events. Fig 2  shows an example of the crude weight 
gain trajectories of a simple random sample of 100 nor-
mal weight women, illustrating the longitudinal design 
of the study.
We explored the variation in GWG among the sites; 
the variance within sites (59.6%) was six times higher 
than the variance between sites (9.6%). The all sites’ 
SD for GWG ranged from 1.45 kg at 14-19+6 weeks’ gesta-
tion to 1.61 kg at 34-40 weeks’ gestation. Within five 
gestational age windows from 14 weeks to 40+0 weeks, 
representing 40 comparisons, 37 had standardised site 
differences (SSDs) ≤0.5 (as prespecified in the proto-
col) of the SD of all sites combined (fig 3 , table 2). The 
three comparisons that were higher than 0.5 SSD were 
from China, but the difference was <0.5 at 14-18+6 
weeks’ gestation and at 34-40 weeks’ gestation (0.34 
and 0.21, respectively).
The mean GWGs were 1.64 kg, 2.86 kg, 2.86 kg, 2.59 
kg, and 2.56 kg for the gestational age windows 14-18+6 
weeks, 19-23+6 weeks, 24-28+6 weeks, 29-33+6 weeks, and 
34-40+0 weeks, respectively (table 2 ). Of all the weight 
measurements, 71.7% (10 639/14 846) and 94.9% 
(14 085/14 846) fell within the expected 1 SD and 2 SD 
thresholds, respectively, which compares well with 
68% and 95% theoretically expected under normality 
assumptions. On average, across all gestational ages, 
the absolute magnitude of differences between the 
observed (empirical) and smoothed centiles was 0.18 kg 
for the median, 0.37 kg for the 3rd centile, and 0.06 kg 
for the 97th centile (fig 4).
Table 3  provides the values of the smoothed week 
specific GWG according to gestational age of selected 
centiles (that is, 3rd, 10th, 25th, 50th, 75th, 90th, and 
97th), which are shown graphically in figure 5 . We have 
also provided the corresponding equations for the 
mean and SD from the multilevel regression model 
(table 4), allowing for calculation of any desired cen-
tiles according to gestational age in exact weeks. For 
example, centiles can be calculated as mean ±z×SD, 
table 1 | baseline characteristics and pregnancy outcomes of the normal-weight women. 
values are mean (sD) for continuous variables, and number (percentage) for categorical 
variables
normal bMi (n=3097)
Parents
Maternal age (years) (SD) 28.2 (3.8)
Maternal height (cm) (SD) 162.3 (5.9)
Maternal weight (kg) (SD) 57.2 (6.5)
Paternal height (cm) (SD) 174.2 (7.3)
Body mass index (SD) 21.7 (1.8)
Gestational age at first visit (weeks) (SD) 11.9 (1.4)
Years of formal education (years) (SD) 15.1 (2.9)
Haemoglobin level before 15 weeks’ gestation (g/dL) (SD) 12.5 (1.1)
Married/cohabiting (%) 3020 (97.3)
Nulliparous (%) 2230 (71.8)
Pre-eclampsia (%) 12 (0.4)
Pyelonephritis (%) 9 (0.3)
Any sexually transmitted infection (%) 1 (0.0)
Spontaneous initiation of labour (%) 2127 (68.5)
PPROM (<37 weeks’ gestation) (%) 46 (1.5)
Caesarean section (%) 1036 (33.4)
Mother admitted to intensive care unit (%) 9 (0.3)
Infants
NICU admission >1 day (%) 160 (5.2)
Preterm (<37 weeks’ gestation) (%) 125 (4.0)
Preterm and spontaneous onset of labour (%) 82 (2.6)
Term LBW (<2500 g; ≥37 weeks) (%) 99 (3.2)
Birth weight >4.0 kg (%) 144 (4.7)
Neonatal mortality (%) 4 (0.1)
Male sex (%) 1534 (49.4)
Exclusive breastfeeding at discharge (%) 2698 (86.9)
Mean (SD) weight (kg) (≥37 weeks’ gestation) 3.2 (0.4)
Mean (SD) length (cm) (≥37 weeks’ gestation) 49.3 (1.9)
Mean (SD) head circumference (cm) (≥37 weeks’ gestation) 33.8 (1.3)
PPROM=preterm pre-labour rupture of membranes; NICU=neonatal intensive care unit; LBW=low birthweight.
Gestational age (weeks)
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Fig 2 | trajectories of gestational weight gain of 100 
randomly selected normal weight healthy women with 
uncomplicated live singleton births
Gestational age (weeks)
SS
D 
ex
pr
es
se
d 
in
 u
ni
ts
 o
f S
D
14-18 19-23 24-28 29-33 34-40
-2
0
1
-0.5
0.5
2
-1
Brazil IndiaChina Kenya
Oman USUK Italy
Fig 3 | standardised site difference (ssD) for gestational 
weight gain in the Fetal growth longitudinal study of the 
intergrOWtH-21st Project. ssD calculated by (site mean of 
gestational weight gain at each gestational age interval 
minus all sites mean of gestational weight gain at the same 
gestational age interval)/all sites’ sD of gestational weight 
gain at the same gestational age interval. ssD was 
adjusted at median gestational age for all sites at each 
gestational age interval
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where z is −1.88, −1.645, −1.28, 0, 1.28, 1.645, and 1.88 for 
the 3rd, 5th, 10th, 50th, 90th, 95th, and 97th centiles, 
respectively.
The sensitivity analyses performed to assess the 
impact of potential misclassification of BMI status 
resulted in 30% (932/3097) of women being excluded 
from the normal weight group and 53% (n=639/1216) of 
women being added from the overweight group to form 
a reclassified group of normal weight women (n=2804 
women, 17 579 observations). The resultant centile val-
ues were remarkably similar and indistinguishable 
when we superimposed them on the normal weight 
GWG chart. Sensitivity results when we excluded 
women with caesarean sections had minimal effect 
compared with results using all the data (data not 
shown).
Tables containing the mean and SD, centile values, 
and z scores by gestational age, expressed in completed 
weeks’ gestation (as recommended by WHO ICD1044), 
and printable charts are available atwww.inter-
growth21.org.
discussion
Principal findings
Despite the range of cultures, behaviours, clinical prac-
tices, and traditions, which can strongly influence ges-
tational weight gain (GWG), we observed strikingly 
similar patterns of weight gain in the populations stud-
ied, reflecting their overall good health and living con-
ditions, nutritional status, and access to adequate 
standardised healthcare. The proportion of total vari-
ance explained by population differences was <10% of 
the total variance. This finding indicates not only that 
separate GWG charts for women from different ethnic/
racial groups are not required, as is the case for growth 
standards from early pregnancy to 5 years of age,24 26 27 
but that the observed differences by race/ethnicity 
reported in some studies45-48 are more likely caused by 
socioeconomic, medical, cultural, and nutritional fac-
tors than true biological differences in the process of 
nutrient absorption or fat deposition among healthy 
women. We adopted a prescriptive approach, employed 
highly trained anthropometrists to measure maternal 
weight prospectively in duplicate, and used uniform 
and standardised measurement equipment and proto-
cols. We used the patterns in weight gain in women with 
a normal BMI in early pregnancy to produce interna-
tional standards, using statistical techniques that 
account for repeated measurements within women at 
one site and between women across sites. We developed 
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Fig 4 | Fitted 3rd (bottom dashed line), 50th (middle dashed 
line), and 97th (top dashed line) smoothed centile curves 
for gestational weight gain among normal weight women. 
large blue circles show empirical values for each week of 
gestation, and small grey circles show actual observations
table 2 | all sites and individual site means (sD) for gestational weight gain (kg) of 
normal weight women
gestational age and 
Country no of measures
adjusted mean (sD) 
gWg (kg)
standardised site 
difference (ssD)*
14-18+6 weeks
Brazil 252 1.84 (1.34) 0.14
China 476 2.14 (1.28) 0.34
India 441 1.36 (1.30) −0.20
Kenya 355 1.52 (1.65) −0.09
Oman 360 0.96 (1.53) −0.47
UK 408 1.83 (1.44) 0.13
USA 221 1.79 (1.40) 0.10
Italy 392 1.71 (1.29) 0.05
All 2905 1.64 (1.45) 0.00
19-23+6 weeks
Brazil 252 2.62 (1.11) −0.16
China 485 4.00 (1.57) 0.79
India 448 2.22 (1.33) −0.43
Kenya 356 2.57 (1.46) −0.20
Oman 366 2.73 (1.31) −0.08
UK 413 2.80 (1.26) −0.04
USA 211 2.84 (1.40) −0.01
Italy 384 2.75 (1.24) −0.07
All 2915 2.86 (1.46) 0.00
24-28+6 weeks
Brazil 251 2.81 (1.46) −0.04
China 448 3.77 (1.68) 0.62
India 455 2.37 (1.40) −0.34
Kenya 360 2.48 (1.29) −0.26
Oman 370 2.91 (1.39) 0.03
UK 412 2.81 (1.27) −0.04
USA 204 2.97 (1.30) 0.07
Italy 375 2.75 (1.35) −0.08
All 2875 2.86 (1.47) 0.00
29-33+6 weeks
Brazil 261 2.53 (1.43) −0.04
China 545 3.41 (1.61) 0.55
India 428 2.28 (1.48) −0.21
Kenya 355 2.18 (1.39) −0.27
Oman 363 2.43 (1.39) −0.11
UK 417 2.59 (1.23) 0.00
USA 216 2.52 (1.73) −0.04
Italy 373 2.37 (1.35) −0.15
All 2958 2.59 (1.51) 0.00
34-40+0 weeks
Brazil 269 2.48 (1.57) −0.05
China 485 2.91 (1.40) 0.22
India 406 2.19 (1.30) −0.23
Kenya 388 2.42 (2.41) −0.09
Oman 406 2.60 (1.36) 0.02
UK 534 2.61 (1.26) 0.03
USA 220 2.68 (2.14) 0.07
Italy 370 2.55 (1.40) −0.01
All 3078 2.56 (1.61) 0.00
*Calculated by: (site mean of GWG−all sites mean of GWG at each gestational age interval)/all sites’ SD of GWG. 
SSD adjusted at median gestational age for all sites at each gestational age interval with estimates from final 
regression model.
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a standard, as well as the accompanying centile chart 
and simple formulae, to allow any desired centiles or z 
scores to be calculated. These tools complement the 
already published fetal growth, neonatal size, and post-
natal growth of preterm infant standards from the 
INTERGROWTH-21st Project.26-28
Comparison with other studies
Comparisons with previous studies on this subject are 
difficult because of wide variations in study designs, 
methods, and populations selected. In particular, some 
studies based GWG on maternally recalled weight 
before pregnancy, while we measured weight using 
standardised methods at the first trimester visit. None-
theless, the weight gain at term of women in the Fetal 
Growth Longitudinal Study (13.7 kg) was comparable 
with the range recommended in 2009 by the Institute of 
Medicine/National Research Council for normal weight 
women (11.5-16.0 kg) and optimal GWG reported for a 
multiethnic Singaporean population (13.7 kg), but 
about 2-3 kg less than that for low risk urban popula-
tions in Leuven, Belgium (15.9 kg) and Pittsburgh, USA 
(16.4 kg).1 16 21 22  Other prospective longitudinal studies 
of healthy women in Mexico City, urban regions of 
Argentina, and rural Malawi reported GWG at term of 
12.1 kg, 10.7 kg, and 3.7-6.4 kg,49-51  respectively, and large 
cross sectional studies of low risk Japanese women, 
well nourished women in Switzerland, and Swedish 
birth registry records have reported singleton term GWG 
of 10.0 kg, 15.5 kg, and 13.8 kg, respectively.17 47 52 All 
these studies were based on country specific popula-
tions and used various classifications of BMI status. 
Furthermore, most of them relied on recalled or rou-
tinely recorded weight measurements from medical 
records or weight data from large population databases 
with questionable measurement sources, validity, and 
reliability.
strengths and limitations of study
We recognise that our study has some limitations. As 
the first weight measurement was taken between 9 
and 13+6 weeks’ gestation, the BMI classification of 
women as normal weight was not based on a value 
from before pregnancy. The results of the post hoc 
sensitivity analysis, however, were reassuring, and 
we believe that the effect of any possible misclassifi-
cation is therefore small. Measurements before preg-
nancy are seldom available in clinical practice or 
research studies, especially in low risk women.53 54 
Recruitment of women who intend to conceive is also 
challenging and might be culturally unacceptable in 
some populations, which would introduce selection 
bias; this could explain why there are few studies 
with measured pre-pregnancy weight, which should 
ideally be used to construct GWG references or stan-
dards. Consequently, clinicians and researchers have 
often relied on self reported pre-pregnancy weight to 
estimate BMI and monitor GWG,55  despite the consid-
table 3 | smoothed centiles for gestational weight gain (gWg) for women of normal weight (bMi 18.50-24.99) according 
to gestational age
gestational 
age (weeks)
no of 
measures
Centiles for gWg (kg)
3rd 10th 25th 50th 75th 90th 97th
14 260 −2.34 −1.73 −1.07 −0.25 0.65 1.54 2.50
15 473 −1.77 −1.14 −0.45 0.39 1.32 2.24 3.23
16 705 −1.26 −0.60 0.13 1.01 1.99 2.95 3.98
17 851 −0.80 −0.09 0.67 1.61 2.64 3.65 4.75
18 639 −0.37 0.38 1.19 2.19 3.29 4.36 5.53
19 324 0.03 0.82 1.69 2.75 3.92 5.07 6.31
20 532 0.41 1.25 2.17 3.30 4.55 5.78 7.11
21 627 0.77 1.66 2.64 3.84 5.17 6.49 7.91
22 715 1.11 2.05 3.10 4.37 5.79 7.19 8.72
23 717 1.45 2.44 3.54 4.90 6.41 7.90 9.52
24 399 1.77 2.82 3.98 5.42 7.02 8.61 10.34
25 500 2.09 3.19 4.42 5.94 7.63 9.31 11.15
26 599 2.40 3.56 4.85 6.45 8.24 10.02 11.97
27 675 2.71 3.93 5.28 6.96 8.85 10.73 12.79
28 702 3.02 4.29 5.71 7.47 9.45 11.43 13.61
29 493 3.33 4.65 6.14 7.98 10.06 12.14 14.44
30 526 3.63 5.01 6.56 8.49 10.67 12.86 15.27
31 533 3.94 5.37 6.99 9.00 11.28 13.57 16.10
32 691 4.24 5.73 7.41 9.52 11.89 14.29 16.94
33 715 4.55 6.10 7.84 10.03 12.51 15.01 17.78
34 498 4.85 6.46 8.27 10.55 13.12 15.73 18.62
35 533 5.16 6.82 8.70 11.06 13.74 16.46 19.47
36 514 5.47 7.19 9.14 11.58 14.37 17.19 20.32
37 858 5.78 7.56 9.57 12.11 14.99 17.92 21.18
38 402 6.10 7.93 10.01 12.63 15.62 18.66 22.04
39 230 6.41 8.30 10.45 13.16 16.25 19.40 22.91
40 82 6.73 8.68 10.89 13.69 16.89 20.15 23.79
Total No of 
measures
14 793 — — — — — — —
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erable limitations of error and recall bias.56  Another 
limitation is that it was not possible to infer the most 
appropriate GWG pattern for women who are under-
weight or obese as our population consisted only of 
healthy women with a BMI range of 18.5-<30. Under-
weight women are at increased risk for several 
adverse outcomes, including fetal growth restriction, 
so adequate GWG is especially important for this 
group.5 57-59 Conversely, the growing problem of 
maternal obesity throughout the world has led to 
great interest in whether limiting GWG can reduce the 
risk of the associated adverse outcomes.1  It could be 
argued that the sample size is relatively small com-
pared with epidemiological studies that have 
reported data from large populations—for example, 
the Danish National Birth Cohort of more than 60 000 
women.60 It is always difficult to reach a balance 
between sample size and data quality, particularly 
when larger samples require the use of routinely col-
lected clinical information. We decided when design-
ing the study that it was more important to have a 
sufficiently large sample, collected prospectively in a 
scientifically robust manner, with standardised 
methods, quality control, and equipment, than a 
larger sample using data that have been routinely 
collected with less rigour and precision.
Policy implications
Our results have several practical implications. Firstly, 
we are aware that in some settings, such as the UK, 
routine weight monitoring is not recommended.15  In 
most countries worldwide and in particular those with 
large populations at risk of under-nutrition, however, 
weight monitoring at antenatal visits is common prac-
tice. Our aim was to contribute to the standardisation 
of weight monitoring and the more systematic use of 
the data obtained. Overall, we suggest that the stan-
dards (as part of first level nutritional screening) can 
be used to alert clinicians to deviations in weight, trig-
gering clinical inquiries as to whether such deviations 
are associated with complications related to preg-
nancy, medical conditions, or eating disorders. We 
would discourage clinicians, however, from telling 
women that deviations are due to pregnancy compli-
cations or recommending immediate behaviour 
changes as our data do not provide sufficient evidence 
for the standards to be interpreted in this way. Sec-
ondly, we believe that consideration should be given 
to referring women who are underweight before preg-
nancy for nutritional advice and treatment if neces-
sary and that it is safe to suggest that during pregnancy 
such women should have GWG at least compatible 
with those of normal weight women. Finally, our data 
cannot be used to make recommendations to under-
weight, overweight, or obese women beyond those 
already provided by NICE.61
Conclusions
In summary, we have described patterns of GWG among 
normal weight women that are compatible with desir-
able healthy pregnancy outcomes, which provide a 
basis to guide clinical recommendations on weight 
gain. To facilitate the use of such recommendations in 
clinical settings, epidemiological studies with data on 
important long term maternal and childhood outcomes 
are needed to identify optimal centile (that is, outcome 
based cut off points) categories associated with the best 
health outcomes. Towards that end, the INTER-
GROWTH-21st Project is currently collecting one and two 
year follow-up data, including postpartum maternal 
weight patterns. We anticipate that the publication of 
this GWG standard will prompt debate among epidemi-
ologists, nutritionists, obstetricians, and midwives 
about what the optimal thresholds should be. We 
believe that this standard is more robust than any other 
available charts and adds to the set of international 
standards from the INTERGROWTH-21st Project, which 
aims to improve pregnancy care practices and out-
comes by establishing benchmarks against which all 
women, their unborn babies, and newborns can be 
compared.26-28
table 4 | equations for estimating mean and standard deviation (sD) of gestational weight gain in normal weight women 
according to exact gestational age (weeks)*
estimate regression equation
Mean; log (GWG) 1.382972−56.14743×GA−2+0.2787683×GA0.5
SD; log (GWG) 0.2501993731+142.4297879×GA−2−61.45345×GA−2×LN(GA)
GA=exact gestational age in weeks.
*All logarithms are natural logarithms. Using equations of mean and SD one can easily compute any desired centiles using relationPth centile=mean+KSD 
whereK is normal equivalent deviate (z score) corresponding to particular centile—for example,K=1.88 for 97th centile and −1.88 for 3rd centile, and SDs 
in this equation are predicted estimates from the regression analysis. For example to calculate gestational weight gain at 34 weeks;
C50 for GWG=exp((1.382972−56.14743×34−2+0.2787683×340.5)+(0×(0.2501993731+142.4297879×34−2 − 61.45345*34−2*LN(34)))) – 8.75
C3 for GWG=exp((1.382972−56.14743×34−2+0.2787683×340.5)+(−1.88×(0.2501993731+142.4297879×34−2 − 61.45345*34−2×LN(34)))) – 8.75
C97 for GWG=exp((1.382972− 56.14743×34−2+0.2787683×340.5)+(1.88×(0.2501993731+142.4297879×34−2 −61.45345*34−2×LN(34)))) – 8.75
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